Towards Healthcare
Cell and Gene Solutions Market Growth Led by Oncology and Rare Disorders

Cell and Gene Solutions Market 2025 to 2034 Global Landscape, Regulatory Momentum, and Strategic Investments

The growing demand for targeted therapeutics and new product launches drives the global market. North America dominated the global market due to the presence of key players and favorable infrastructure.

Content

  • Insight Code: 5902
  • No. of Pages: 150+
  • Format: PDF/PPT/Excel
  • Published: July 2025
  • Report Covered: [Revenue + Volume]
  • Historical Year: 2021-2022
  • Base Year: 2023
  • Estimated Years: 2024-2033

About The Author

Kesiya Chacko is an accomplished market research professional with over 4+ years of experience in the healthcare industry, known for delivering actionable insights and strategic analysis that empower healthcare organizations to navigate complex, rapidly evolving markets.

Kesiya began her research career with Precedence Research, where she built a strong foundation in pharmaceutical and healthcare market analysis. Today, she plays an integral role at Towards Healthcare, contributing to in-depth, client-centric research initiatives. She also brings her expertise to Statifacts, supporting broader research functions with a focus on cross-sector healthcare trends and data interpretation.

Her commitment to high-quality analysis, combined with a strong grasp of regulatory and market dynamics, makes her a trusted contributor to healthcare firms seeking future-ready, data-backed decisions. Kesiya’s work spans the analysis of industry trends, competitive benchmarking, and evaluation of regulatory and innovation-driven shifts.

Talk to us
FAQ's

Global cell and gene solutions market to grow rapidly by 2034, fueled by tech progress and consumer trends.

North America is leading the cell and gene solutions market due to the availability of state-of-the-art research and development facilities, the presence of key players, and favorable regulatory support.

The cell and gene solutions market includes five segments including by therapy type, by service technology, by application, by end-user, and by region.

Some key players include Thermo Fisher Scientific, Charles River Laboratories, and ABL Europe.

CGTs may induce a strong immune response to the protein in the case of replacing proteins from genetic diseases.

Food and Drug Administration, Government of Canada, clinicaltrials.gov, Association of the British Pharmaceutical Industry.
Any Questions